✦ LIBER ✦

Pomegranate juice supplementation in chronic obstructive pulmonary disease: a 5-week randomized, double-blind, placebo-controlled trial

✍ Scribed by Cerdá, B; Soto, C; Albaladejo, M D; Martínez, P; Sánchez-Gascón, F; Tomás-Barberán, F; Espín, J C

Book ID: 110024005
Publisher: Nature Publishing Group
Year: 2005
Tongue: English
Weight: 121 KB
Volume: 60
Category: Article
ISSN: 0954-3007
DOI: 10.1038/sj.ejcn.1602309

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety of regadenoson, a selective adeno

Safety of regadenoson, a selective adenosine A2Aagonist, in patients with chronic obstructive pulmonary disease: A randomized, double-blind, placebo-controlled trial (RegCOPD trial)

✍ Gregory S. Thomas; Bruce R. Tammelin; George L. Schiffman; Rudy Marquez; Deborah 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 687 KB

Treatment with simvastatin in normochole

Treatment with simvastatin in normocholesterolemic patients with Alzheimer's disease: A 26-week randomized, placebo-controlled, double-blind trial

✍ Mikael Simons; Frank Schwärzler; Dieter Lütjohann; Klaus Von Bergmann; Konrad Be 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB 👁 2 views

Pulmonary Function and Electrolyte Balan

Pulmonary Function and Electrolyte Balance Following Spironolactone Treatment in Preterm Infants With Chronic Lung Disease: A Double-Blind, Placebo-Controlled, Randomized Trial

✍ Hoffman, David J; Gerdes, Jeffrey S; Abbasi, Soraya 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 155 KB

No Effect of the Calcium Antagonist, Isr

No Effect of the Calcium Antagonist, Isradipine, on Plasma Catecholamines in Irreversible Chronic Obstructive Pulmonary Disease (COPD). A Randomized, Double-blind, Placebo-controlled Study

✍ Niels A. Graudal; Anders M. Galløe; Inger Plum; Nils Milman; Jesper O. Clausen 📂 Article 📅 1995 🏛 Elsevier 🌐 English ⚖ 243 KB

SUMMARY: Calcium antagonists have been claimed to decrease the pulmonary artery pressure and increase oxygen uptake and cardiac output in patients with chronic obstructive pulmonary disease (COPD). This should tend to decrease the plasma levels of catecholamines. The purpose of the present study was

Clinical trial: the efficacy, impact on

Clinical trial: the efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation – a 12-week, randomized, double-blind, placebo-controlled study

✍ E. M. M. QUIGLEY; L. VANDEPLASSCHE; R. KERSTENS; J. AUSMA 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 275 KB

Clinical trial: the efficacy and tolerab

Clinical trial: the efficacy and tolerability of velusetrag, a selective 5-HT4 agonist with high intrinsic activity, in chronic idiopathic constipation – a 4-week, randomized, double-blind, placebo-controlled, dose–response study

✍ M. Goldberg; Y.-P. Li; J. F. Johanson; A. W. Mangel; M. Kitt; D. T. Beattie; K. 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 311 KB